GlassScriptPhysician profile
Charles J Davidson
NPI 1922062413
$61,918.37
in general payments reported to CMS, 2019-2025
8 companies · $59.23 in 2025
The $59.23 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $13K · 2021: $1,257 · 2022: $16K · 2023: $5,223 · 2024: $8,776 · 2025: $59.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,000 · Travel and Lodging: $3,501 · Food and Beverage: $3,057 · Honoraria: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,000.00 |
| Travel and Lodging | $3,500.58 |
| Food and Beverage | $3,057.39 |
| Honoraria | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $35,985.75 | 2019-2025 | Pascal, Evoque, Sapien 3 Ultra Resilia |
| Philips North America LLC | $20,497.62 | 2022-2024 | (9520) Igt Devices Undivided, (Bh4) Igt Devices Undivided |
| Abbott Laboratories | $3,795.01 | 2019-2023 | Mitraclip |
| Croivalve INC | $1,619.15 | 2023 | |
| W. L. Gore & Associates, INC. | $20.84 | 2021 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Davidson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.